-
List of 36 life─saving drugs exempted from custom duty in India through Union Budget 2025─26
13 Feb 2025 07:35 GMT
… ]
List of 36 life-saving drugs exempted from custom duty in … Budget 2025-26
S. No.
Drug Name
1
Onasemnogene abeparvovec
2 …
Inclisiran
34
Agalsidase Beta
35
Imiglucerase
36
Eptacog alfa activated recombinant …
-
36 Essential Drugs Become Cheap with Budget 2025, See Full List
01 Feb 2025 14:15 GMT
… Exemption on 36 Life-Saving Drugs
Medicines for cancer and rare … Inclisiran
34
Agalsidase Beta
35
Imiglucerase
36
Eptacog Alfa (activated … drugs include:
Pembrolizumab (MSD Pharmaceuticals) – Cancer immunotherapy
Lorlatinib (Pfizer) – Lung cancer treatment …
-
Budget 2025: Cancer Care, Rare Diseases, Heart Attack Prevention Drugs On 'Lifesaving' List Now
01 Feb 2025 14:01 GMT
… specified drugs and medicines provided under ‘patient assistance programmes’ run by pharmaceutical … be controlled by regular medicines and diet.
‘Imiglucerase’ – also a part … “The establishment of daycare cancer treatment centres in each district hospital …
-
Budget 2025: FM announces full custom duty exemption for 36-life saving drugs; full list of medicines here
01 Feb 2025 10:23 GMT
… drugs, expanding the government’s efforts to make critical treatments … The list includes crucial medications such as Onasemnogene … production costs for pharmaceutical companies.
Addressing the …
Inclisiran
Agalsidase Beta
Imiglucerase
Eptacog Alfa (activated …
-
FDA cites contamination concerns in warning to Sanofi MA plant
22 Jan 2025 14:50 GMT
… (cGMP) for drug substance production.
“FDA documented that approximately … can reproduce an active pharmaceutical ingredient (API) with … from both the FDA and European Medicines Agency (EMA) … both Fabrazyme and Cerezyme (imiglucerase for injection) – the …
-
ISU Abxis’ Gaucher disease drug enters Middle East-North African market
12 Dec 2024 07:07 GMT
… of its Gaucher disease treatment Abcertin (imiglucerase) in the Middle East … East 2024,” an international pharmaceutical and biotechnology exhibition, held at … manufactures, distributes its generic pharmaceutical products and performs contract manufacturing …
-
Rare Diseases With FDA-Approved Treatments | Sentynl Therapeutics, Inc.
08 Sep 2024 19:22 GMT
… of clinical trials required to support an application for FDA approval. …
Miglustat
Eliglustat
Velaglucerase alfa
Imiglucerase
Taliglucerase
Future Developments
While … and medical researchers continue to seek cures, palliative treatments, and drug protocols …
-
FDA Approved Drug Products Approval List July 2024
08 Aug 2024 12:44 GMT
… 3 SOMATROGON-GHLA PFIZER IRELAND PHARMACEUTICALS Approval 07… 210951 SUPPL-17 APALUTAMIDE JANSSEN BIOTECH Manufacturing (CMC) Approval 07 … CEREZYMEBLA #020367 SUPPL-121 IMIGLUCERASE GENZYME Approval 07… #47;31/2024 MEDICAL AIR, USPNDA #219709 …
-
Human medicines European public assessment report (EPAR): Cerezyme, imiglucerase, Date of authorisation: 17/11/1997, Revision: 32, Status: Authorised
23 May 2024 09:19 GMT
Cerezyme is used for the long-term treatment of patients with Gaucher disease. Gaucher disease is a rare inherited disorder, in which people do not have enough of an enzyme called acid beta-glucosidase, which normally breaks down a fatty waste product …
-
Neuronopathic therapies are a serious unmet need in the treatment of Gaucher disease
19 Oct 2023 12:16 GMT
… include Sanofi’s Cerezyme (imiglucerase), Takeda’s VPRIV ( … the creation of drugs designed to cross … with fast-track FDA designation, PR001 treatment could significantly … Looking ahead, collaboration between pharmaceutical innovators, dedicated researchers, …